Publication of a Prospectus and Circular

RNS Number : 6521A
HydrogenOne Capital Growth PLC
26 September 2022
 

LEI: 213800PMTT98U879SF45

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS ANNOUNCEMENT WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY.

 

26 September 2022

HydrogenOne Capital Growth plc

Publication of Prospectus and Circular

HydrogenOne Capital Growth plc ("HGEN or the "Company") is pleased to announce the publication of the Prospectus and Circular in connection to the implementation of a share issuance programme (the "Share Issuance Programme").

The Share Issuance Programme provides the Company with the ability to issue Shares over a period of time in order to satisfy market demand in an expeditious and straightforward manner.  Monies raised pursuant to each Issue will be invested in accordance with the Company's investment objective and investment policy into the pipeline of Hydrogen Assets identified by the Investment Adviser from time to time.

The size and frequency of each Issue, and of each placing, open offer, offer for subscription and intermediary offer component of each issue, will be determined in the sole discretion of the Company in consultation with Panmure Gordon.  In relation to each Issue, which includes either an offer for subscription, an open offer and/or an intermediary offer component, a new securities note and a new summary will be published.  An announcement of each Issue under the Share Issuance Programme will be released through a Regulatory Information Service, including details of the type and number of Shares to be allotted and the method for calculation of the relevant Share Issuance Programme Price.

The Company has convened a General Meeting at 11:00 a.m. on 19 October 2022 at which Resolutions related to the implementation of the Share Issuance Programme will be tabled.

The Prospectus and Circular will be available on the Company's website (www.hydrogenonecapitalgrowthplc.com), at the Company's registered office at 6th Floor, 125 London Wall, London, EC2Y 5AS, and at the National Storage Mechanism via  https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

 

For further information, please contact:

 

HydrogenOne Capital - LLP Investment Adviser

JJ Traynor/ Richard Hulf  Tel: +44 20 3830 8231

 

 

Panmure Gordon - Sponsor and Financial Adviser

Tom Scrivens  Tel: +44 20 7886 2648

Alex Collins   Tel: +44 20 7886 2767

 

 

FTI Consulting  Tel: +44 20 3727 1725

Matthew O'Keefe  Tel: +44 78 1492 1439

Cally Billimore      hygen@fticonsulting.com  

 

IMPORTANT INFORMATION

Neither this announcement, nor any copy of it, may be taken or transmitted, published or distributed, directly or indirectly, in or into the United States or any other jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction. This Announcement is for information purposes only and does not constitute an offer to sell or issue, or the solicitation of an offer to buy, acquire or subscribe for any shares in the Company.

 

The Ordinary Shares have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with the securities laws of any state or other jurisdiction of the United States.

 

This announcement has been issued by, and is the sole responsibility of, the Company. No undertaking, representation, warranty or other assurance, express or implied, is made or given by or on behalf of the Company or any member of the Company's group, HydrogenOne Capital LLP, Panmure Gordon (UK) Limited ("Panmure Gordon") or any of their respective directors, officers, partners, employees, agents or advisers or any other person as to the accuracy or completeness of the information or opinions contained in this announcement and no responsibility or liability is accepted by any of them for any such information or opinions or for any errors, omissions or misstatements, negligence or otherwise in this announcement.

 

Panmure Gordon is authorised and regulated in the UK by the FCA and is acting as sponsor, financial adviser and bookrunner to the Company in connection with the Share Issuance Programme. Panmure Gordon is not acting for, and will not be responsible to, any person other than the Company for providing the protections afforded to its customers or for advising any other person on the contents of this announcement or on any transaction or arrangement referred to in this announcement. No representation or warranty, express or implied, is made by Panmure Gordon as to, and no liability is accepted by Panmure Gordon in respect of, any of the contents of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDILFMMTMTATBJT
UK 100

Latest directors dealings